Cantor Fitzgerald and RBC Capital Stay Bullish on Legend Biotech (LEGN)

1 day ago 5

Ali Ahmed

Fri, January 9, 2026 astatine 11:07 AM CST 2 min read

Legend Biotech Corporation (NASDAQ:LEGN) is 1 of the 12 Stocks that Will Bounce Back According to Wall Street Analysts. On December 17, Cantor Fitzgerald maintained its Overweight standing connected Legend Biotech Corporation (NASDAQ:LEGN) with a terms people of $74. The steadfast said the banal has travel nether unit due to the fact that of concerns astir competition, adjacent though the company’s crab therapy, Carvykti, is inactive connected way to turn astir 100% year-over-year to scope astir $2 cardinal successful income successful 2025.

Legend Biotech Corporation’s (NASDAQ:LEGN) partner, Johnson & Johnson (NYSE:JNJ), has maintained its outlook for Carvykti to execute highest income implicit $5 cardinal successful the increasing aggregate myeloma market. This forecast was reaffirmed astatine a post-American Society of Hematology gathering with analysts.

Cantor Fitzgerald and RBC Capital Stay Bullish connected Legend Biotech (LEGN)

According to estimates by Cantor Fitzgerald, Legend Biotech Corporation (NASDAQ:LEGN) is trading astatine an endeavor worth to existent income aggregate of astir 3x and an endeavor worth to highest income aggregate of astir 1x. The probe steadfast sees Legend Biotech Corporation (NASDAQ:LEGN) arsenic “one of the champion values successful biotech” due to the fact that of its prospects for beardown gross maturation and expectations for the institution to go profitable successful 2026.

Earlier, connected December 9, RBC Capital besides reiterated its Outperform standing connected Legend Biotech Corporation (NASDAQ:LEGN) with a terms people of $74. The steadfast believes that Carvykti remains “potentially the highest efficacy option” with “one-and-done convenience.” RBC Capital recommends buying the banal during periods of weakness based connected its expectations for near-term profitability and continued maturation successful 2026.

Legend Biotech Corporation (NASDAQ:LEGN) is simply a planetary biotechnology and compartment therapy institution focused connected discovering, developing, and commercializing caller compartment therapies for crab and different superior diseases.

While we admit the imaginable of LEGN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best US Penny Stocks to Buy and 10 Best New Penny Stocks to Invest In.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.